Evidence map›Paper›PMID 41748965›Full record

ArticleJournal of cancer research and clinical oncology2026

Racial/ethnic and sex disparities in mortality among US cancer survivors.

Qi Xiong, Yu Luo, Kun Han, Yao Pan, Jue Wang, Jingke He, Junkun Li, Wenhao Xu, Tingxiu Xiang, Shuai Su and 1 more

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qi Xiong *The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yu Luo *Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Kun Han *Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yao Pan *Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Jue WangDepartment of Urology, Panzhihua Central Hospital, Panzhihua, China.
Jingke HeDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Junkun LiDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wenhao XuPanzhihua Central Hospital, Panzhihua, China. pzh2238008@126.com.
Tingxiu XiangThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China. xiangtx1@cqu.edu.cn.
Shuai SuDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. sushuai930809@163.com.
Chengcheng WeiDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. chengchengwei98@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgrondCancer survivors in the United States face significant disparities in mortality influenced by race and sex. Despite advances in cancer treatment, the disparities of social determinants, behavioral health, and metabolic risk factors remain underexplored.

methodsAnalysis was based on the data from the National Health and Nutrition Examination Survey (NHANES) linked to the National Death Index and the follow-up data up to December 31, 2019. Survey-weighted multiple Cox regression was employed to assess the relationships of multiple risk factors and all-cause mortality. Analyses were informed by a conceptual causal framework (Directed Acyclic Graph). We performed an explanatory decomposition analysis to quantify the collective explanatory role of social determinants of health (SDoH) in the observed racial disparity.

resultsDuring median follow-up of 8.5 years, 2269 cancer survivors out of 6028 participants experienced all-cause mortality. In weighted analyses, we observed Black survivors had highest mortality rates (32.4%), followed by White (26.8%). Before covariables adjustment, Black had a higher all-cause mortality (HR 1.40, 95% CI 1.24-1.59) compared to the Whites. After adjustment of all covariables, there was no significant difference in mortality. Female cancer survivors had lower mortality rate (21.7%) and lower hazard ratio (HR 0.72, 95% CI 0.63-0.81). The analysis identified independent risk factors for increased mortality, including unemployment, lower family income, lack of private health insurance, current smoking, poor diet, physical inactivity, suboptimal sleep, hypertension, and diabetes. Central obesity was associated with lower mortality (HR 0.74, 95% CI 0.64-0.86), a finding that requires cautious interpretation due to potential reverse causation and confounding. Exploratory decomposition analysis suggested SDoH collectively explained a substantial portion of the unadjusted Black-White mortality difference.

conclusionIn this mixed population of cancer survivors, a higher burden of social and behavioral risk factors was associated with increased mortality. The findings underscore the critical need to integrate SDoH assessment and mitigation into long-term survivorship care to address social determinants and health behaviors to promote equity in survivorship outcomes. Future research with detailed clinical data is needed to disentangle the effects of cancer type and stage from post-diagnostic factors.

Indexed as

Cancer SurvivorsEthnicityHealth Status DisparitiesNeoplasmsAdultAgedBlack or African AmericanFemaleFollow-Up StudiesHumansMaleMiddle AgedNutrition SurveysRisk FactorsSex FactorsSocial Determinants of HealthAll-cause mortalityCancer survivorsNational health and nutrition examination survey (NHANES)Race/sex disparitiesSocial determinants of health (SDoH)

Identifiers

PMID41748965
PMCPMC12946577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.